Roger Bate

Summary

Affiliation: American Enterprise Institute
Country: USA

Publications

  1. ncbi Does price reveal poor-quality drugs? Evidence from 17 countries
    Roger Bate
    American Enterprise Institute, Washington, DC 20036, USA
    J Health Econ 30:1150-63. 2011
  2. ncbi Assessing website pharmacy drug quality: safer than you think?
    Roger Bate
    American Enterprise Institute, Washington, District of Columbia, USA
    PLoS ONE 5:e12199. 2010
  3. ncbi Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments
    Roger Bate
    American Enterprise Institute, Washington, D C, USA
    Malar J 9:157. 2010
  4. ncbi Pilot study of essential drug quality in two major cities in India
    Roger Bate
    Africa Fighting Malaria, Washington, DC, USA
    PLoS ONE 4:e6003. 2009
  5. ncbi Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions
    Roger Bate
    Africa Fighting Malaria, Washington, D C, USA
    Malar J 8:33. 2009
  6. ncbi USAID's health challenge: improving US foreign assistance
    Roger Bate
    American Enterprise Institute of Public Policy Research, Washington DC, USA
    J R Soc Med 100:29-33. 2007
  7. ncbi Drug procurement, the Global Fund and misguided competition policies
    Richard Tren
    Africa Fighting Malaria, Washington, DC, USA
    Malar J 8:305. 2009
  8. ncbi Antimalarial drug quality in the most severely malarious parts of Africa - a six country study
    Roger Bate
    Africa Fighting Malaria, Washington, DC, United States of America
    PLoS ONE 3:e2132. 2008
  9. ncbi The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment
    Amir Attaran
    Institute of Population Health and Faculty of Law, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada
    Lancet 368:247-52. 2006
  10. ncbi Malaria control and public health
    Donald Roberts
    Emerg Infect Dis 10:1170-1; author reply 1171-2. 2004

Detail Information

Publications10

  1. ncbi Does price reveal poor-quality drugs? Evidence from 17 countries
    Roger Bate
    American Enterprise Institute, Washington, DC 20036, USA
    J Health Econ 30:1150-63. 2011
    ..These findings suggest that consumers are likely to suspect low quality from market price, non-innovator brand and the look of the pharmacy, but none of these signals can perfectly identify substandard and counterfeit drugs...
  2. ncbi Assessing website pharmacy drug quality: safer than you think?
    Roger Bate
    American Enterprise Institute, Washington, District of Columbia, USA
    PLoS ONE 5:e12199. 2010
    ..S. Food and Drug Administration (FDA) works with the National Association of Boards of Pharmacy (NABP) to regularly update a list of websites likely to sell drugs that are illegal or of questionable quality...
  3. ncbi Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments
    Roger Bate
    American Enterprise Institute, Washington, D C, USA
    Malar J 9:157. 2010
    ..Since intelligence provided by investigators indicates that some counterfeit producers may be adapting products to pass Minilab tests, the results are compared with those from a Raman spectrometer and discrepancies are discussed...
  4. ncbi Pilot study of essential drug quality in two major cities in India
    Roger Bate
    Africa Fighting Malaria, Washington, DC, USA
    PLoS ONE 4:e6003. 2009
    ....
  5. ncbi Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions
    Roger Bate
    Africa Fighting Malaria, Washington, D C, USA
    Malar J 8:33. 2009
    ....
  6. ncbi USAID's health challenge: improving US foreign assistance
    Roger Bate
    American Enterprise Institute of Public Policy Research, Washington DC, USA
    J R Soc Med 100:29-33. 2007
  7. ncbi Drug procurement, the Global Fund and misguided competition policies
    Richard Tren
    Africa Fighting Malaria, Washington, DC, USA
    Malar J 8:305. 2009
    ..A tender process based primarily on price cannot account for a company's ability to consistently supply sufficient product in time...
  8. ncbi Antimalarial drug quality in the most severely malarious parts of Africa - a six country study
    Roger Bate
    Africa Fighting Malaria, Washington, DC, United States of America
    PLoS ONE 3:e2132. 2008
    ..The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies in the private sector risks patient safety and, through drug resistance, places the future of malaria treatment at risk globally...
  9. ncbi The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment
    Amir Attaran
    Institute of Population Health and Faculty of Law, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada
    Lancet 368:247-52. 2006
  10. ncbi Malaria control and public health
    Donald Roberts
    Emerg Infect Dis 10:1170-1; author reply 1171-2. 2004